title: Should anthracyclines and dexrazoxane be used for children with cancer?
authors.forename: Elvira C
authors.initials: EC
authors.lastname: van Dalen
authors.forename: Henk
authors.initials: H
authors.lastname: van den Berg
authors.forename: Martine F
authors.initials: MF
authors.lastname: Raphaël
authors.forename: Huib N
authors.initials: HN
authors.lastname: Caron
authors.forename: Leontien C
authors.initials: LC
authors.lastname: Kremer
mesh_terms: D018943:Anthracyclines / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002648:Child; D006321:Heart / Q000187:drug effects; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D016609:Neoplasms, Second Primary / Q000139:chemically induced; D011929:Razoxane / Q000009:adverse effects*
chemical_list: D018943:Anthracyclines; D000970:Antineoplastic Agents; D011929:Razoxane